Home About Us Contact Us

 

Table of Content - Volume 20 Issue 1 - October 2021


 

Isolation and speciation of candida from various clinical samples by using conventional method and chrom agar in a tertiary care centre

 

Gunapravathy Istalingam I1, Dillirani Vedachalam2*, Sridhar Rathinam3

 

1Assistant Professor, Department of Microbiology, Government Thoracic Medicine Hospital/SMC Tambaram Sanitorium, Tambaram, Chennai, Tamil Nadu, INDIA.

{2Professor & HOD, Department of Microbiology} {3Professor & HOD, Department of Chest & Respiratory Medicine} Government Stanley Medical College / GHTM, Chennai, INDIA.

Email: dilliraniveda@gmail.com

 

Abstract              Background: Infections due to Candida especially Non-albicans Candida (NAC) species are increasingly being reported in recent years. Isolation and identification up to species level are of utmost importance in the early management of these infections. aim and objectives: To isolate and speciate Candida using germ tube test, chlamydospore formation test, sugar fermentation test, sugar assimilation test. To evaluate the performance of commercially available chromogenic Candida speciation media i.e HICHROM agar. Results: Among the total of 114 Candida spp., non-albicans candida species 64 (56%) were predominant compared to C.albicans 50 (44%). The age group above 60 years were commonly affected and females 67(59%) were more than male 47(41%). Among non-albicans candida species, C.tropicalis 48(42%) was predominant followed by C.glabrata 7(6%),C.krusei 6(5%) and C.parapsilosis 3(3%). The sensitivity and specificity of HICHROM agar was 100% when compared with conventional methods for isolation of Candida. Conclusion: The advantage of using CHROM agar is that it facilitates the isolation and identification of Candida to species level. The performance of CHROM agar exactly paralleled that of conventional methods. Use of this medium is rapid, technically simple, and cost-effective compared to the time-consuming technically demanding expensive conventional method.

Key words: Candida albicans, Hicrome agar, Non albicans Candida.

 

INTRODUCTION

Yeast-like fungi are ubiquitous. Yeast-like fungi particularly Candida species are the commonest cause of fungal infections. Candidiasis is a primary or secondary infection involving a member of the genus Candida, however, the disease is an infection caused by Candida albicans.1 Candida spp. is a member of the normal flora of the skin, mucous membranes, and gastrointestinal tract. They are endogenous opportunists which cause secondary infection in individuals with some underlying immunocompromised conditions. Candidiasis is a common fungal disease found in humans affecting mucosa, skin, nails, and internal organs of the body. Candida albicans is generally considered the major pathogen among the Candida species. An increase in the prevalence of non-albicans species has been noted during the last decades.2,3 There is growing evidence of the increasing use of azoles causing this epidemiological shift. Characterization to species level helps to identify those strains which might be intrinsically resistant to some of the antifungal agents.4,5 Speciation of Candida isolates is conventionally done by germ tube test, sugar assimilation, and sugar fermentation tests. Newer methods include CHROM agar, API systems, Vitek 2 ID system, and molecular methods.6,7 Germ tube test is a rapid method to differentiate C. albicans and C. dubliniens from other Candida spp. For further speciation chlamydospore formation test, sugar fermentation test, and sugar assimilation test can be done. But these tests are time-consuming and labor-intensive. Among the newer tests, CHROM agar is rapid and cost-effective as compared to other expensive systems like API systems, Vitek 2 ID system, and molecular methods.8

 

METHODS AND MATERIALS

The study was carried out between November 2019 - 0ctober 2020 in the Department of Microbiology, Government Thoracic Medicine Hospital, Tambaram Sanitorium, Tambaram, Chennai after obtaining Ethical clearance. A total of 114 new consecutive Candida isolates from various clinical specimens like a high vaginal swab, midstream clean-catch urine, Catheterized urine, blood, sputum, pus, and skin scraping from patients with candidiasis were included in the study.

Inclusion criteria: The study includes Candida isolates from various clinical samples sent routinely to the Microbiology laboratory.

Exclusion criteria: Patients on any antifungal therapy 6 weeks prior to sample collection. These specimens were processed for the isolation of Candida spp. using standard Mycology methods. Gram staining was performed from the direct specimen and the specimens were inoculated on to Sabouraud’s dextrose agar slants, incubated at 37°C for 24 hrs. A germ tube test was done and the positives identified were either C. albicans or C. dubliniensis. C. albicans were further identified by growth at 45°C and Chlamydospore formation on cornmeal agar. All the 114 isolates were subjected to a Sugar fermentation test and Sugar assimilation test for final confirmation of species. Simultaneously the Candida spp. were inoculated on CHROM agar and incubated at 37°C for 24 hrs and the species were identified by type and color of the colonies on CHROM agar media as per the manufacturer’s instructions. (Table1)

 

Table 1: Colour of various Candia spp.on CHROM agar for identification

Sl.no

Name

Colour on CHROM agar

1

Candida albicans

Light green

2

Candida tropicalis

Blue with pink halo

3

Candida krusei

Pink

4

Candida glabrata

Pink to purple

5

Candida parapsilosis

Cream to pale pink

 

Figure 1: Gram positive budding yeast; Figure 2: Germ tube test positive Cells with pseudohyphae

 

Figure 3: Colour of Candida colonies on CHROM agar

 

RESULT

A total of 114 Candida spp. Were isolated from a various clinical specimen. Among them non albicans candida species 64(56%), were predominant compared to C.albicans 50(44%).Non albicans Candida species included C.tropicalis 48(42%),C.glabreta 7(6%),C.krusei 6(5%) and C.parapsilosis (3%)

Table 2: age group distribution

Age(years)

No. of patients (n=114)

Percentage(%)

0-10

3

3

11-20

3

3

21-30

15

13

31-40

23

20

41-50

15

13

51-60

20

18

>61

35

30

 

Table 3: Distribution of different species of Candida

Candida species

No of isolates (n=114)

Percentage(%)

Candida albicans

50

44

Candida tropicalis

48

42

Candida glabrata

07

6

Candida Kruse

06

5

Candida parapsilosis

03

3

 


Graph 1: Gender wise distribution of Candida


 


Table 4: Species distribution of Candida among various clinical sample

Sl.no

Clinical specimen

Several Candida spp. (n-114)

Candida spp. Identified

 

 

 

C.albicans (n=50)

C.tropicalis (n=48)

C.glabrata (n=7)

C.krusei (n=6)

C.parapsilosis (n=3)

1

Urine

55(48%)

29(58%)

20(42%)

3(43%)

2(33%)

1(33)

2

High vagainal swab

20(18%)

09(18%)

09(19%)

-

1(17%)

1(33)

3

Sputum

19(17%)

07(14%)

10(21%)

-

-

1(33)

4

Pus

12(10%)

4( 8%)

05(10%)

2(28.5%)

2(33%)

-

5

Skin scraping

8(7%))

1( 2%)

04( 8%)

2(28.5%)

1(17%)

-

 

Table 5: Sensitivity and Specificity of CHROM agar for identification of various species of Candida

Sl.no

Candida spp.

No.of Candida spp. identified by a conventional method

No.of Candida spp. identified using CHROM agar

Sensitivity of CHROM agar

Specificity of CHROM agar

1

C. albicans

50

50

100%

100%

2

C. tropicalis

48

48

100%

100%

3

C. glabrata

07

07

100%

100%

4

C. krusei

06

06

100%

100%

5

C.parapsilosis

03

03

100%

100%

 


DISCUSSION

Candida species colonize the mucosal surfaces of all humans soon after birth.3 The increasing incidence of iatrogenic Candida infections and the infections in immunocompromised and immunosuppressed individuals was due to the collective role of the fungal virulence factors and host susceptibility. In the immunocompetent host, several conditions predispose to fungal infections like prolonged antibacterial therapy, corticosteroid use, integumentary breach as in intravenous or intra-arterial catheters, surgical procedures, poor nutritional status, and metabolic derangements.3 The extensive use of antimycotic drugs for prolonged therapeutic courses led to a change in the relative prevalence of various species of Candida.1,7 Many studies in the past decade showed the isolation of various species of Candida and an increase in isolation of nonalbicans Candida in these situations and similar results were obtained in the present study. In our study, out of 114 Candida isolates, 64 (56 %) were non-albicans candida and 50(44%) were Candida albicans which was similar with the study by Rakeh Kumar Mukhia et al.13 reported 56% of non-albicans candida and 44% of Candida albicans. Jayalakshmi L et al.5 in her study documented 68.57% of non-albicans candida and 31.42% Candida albicans. However, Vaishali Wabale et al.24 and Shaheen MA et al.19 reported Candida albicans was higher in their study, 76% and 56% respectively. We observed that the frequent isolation of Candida species was in the age group above 60 years, 30% which was similar with the study of Rakeh Kumar Mukhia et al.13 who reported highest isolation of Candida in the age group above 60 years (34%) and R A Kashid et al.2 also reported Candida isolates was high in the age group above 60 years (24.48%). This could be due to lowered host defence at extremes of age. In the present study, most of the Candida isolates was found to be higher in female patients 67(59%) as compared to male 47(41%).This was similar with the study by Rakeh Kumar Mukhia et al.13 and Amar C S et al.1 who isolated candida species more from females 54(54%) and 62(60.2%) respectively than male patient 46(46%) and 41(39.8%) respectively. Our study differed from R A Kashid et al(12 who reported the isolation of Candida species was higher in Male 81(55.10%) as compared to females 66(44.8%).The reason for higher candida isolates in female is due to vaginal yeast infection, pregnancy and prolonged antibiotic therapy. In our study the incidence of non-albicans candida was 56% and C.albicans 44%.Various studies stated that the incidence of non-albicans candida ranges from 54-75%.20 A study by Vijaya et al.23 showed non-albicans candida (54.1%) to have a higher incidence than C.albicans(45.9%). A study by Manchanda et al.9 showed non-albicans candida (72.4%) to have a higher incidence than C.albicans (27.5%). Among the non-albicans species, Candida tropicalis (42%) was the predominant isolate followed by Candida glabrata (6%), Candida krusei (5%) and C. parapsilosis (3%). C. tropicalis is the most virulent of the non- albicans candida, this may be due to its ability to adhere to epithelial cells and its ability to secrete moderate levels of proteinases.12 In our study most of the Candida were isolated from Urine specimen (48%), followed by High vaginal swab (18%), sputum (17%), pus (10%) and skin scrapings(7%).A study by S. Mohan et al.11 says that most of the isolates were from Urine followed by respiratory specimen, pus, vaginal swab, CSOM, Blood and stool. However Jayalakshmi et al.5 isolated Candida more in sputum specimen (31%) followed by Urine specimen (28%). The conventional methods and the CHROM agar method were compared and were found to give similar results. This was similar to the findings of Sagar K et al.18 Nayaket al.14, who found that CHROM agar showed 100% specificity and 100% sensitivity when compared to SDA and conventional methods. The advantages of HICROM agar are easy to prepare, i.e. boiling, facilitate the rapid isolation and identification of yeast species. HICHROM agar facilitates identification between yeast spp. from specimens containing mixture of yeast spp. and do not affect the viability on subsequent subcultures. HICROM agar has the advantage of rapid identification of Candida spp, technically simple, rapid and cost-effective compared to technically demanding, time consuming and expensive conventional methods.

 

CONCLUSIONS

Along with Candida albicans, non-albicans Candida spp like C. tropicalisC. kruseiC. glabrata, and C. dubliniensis are increasingly being isolated from clinical samples. CHROM agar is a simple, rapid, and inexpensive method for the identification of such species. Characterization to species level helps to identify species that might be intrinsically resistant to commonly used antifungal agents. The accurate species identification of Candida is important for the treatment because not all species respond to the same treatment and also because of the increasing antifungal resistance. CHROMagar is a convenient and rapid method of identification of Candida species, especially in resource-limited poor settings.

 

References

  1. A. cs et. Study of prevalence and antifungal susceptibility of candida. Int j pharm bio sci4, 361 – 381 (2013).
  2. Al., R. A. K. et. Characterisation and antifungal susceptibilty testing for candida species in a tertiary care hospital. J. Heal. Sci. Res.2, (2011).
  3. B, V. K., G, A. K., Swapna, M. and Easow, J. M. Isolation and identification of candida species from various clinical samples in a tertiary care hospital. 5, 3520–3522 (2017).
  4. Golia, S., Reddy, K. M., Karjigi, K. S. and Hittinahalli, V. Speciation of Candida using chromogenic and cornmeal agar with determination of fluconazole sensitivity. Al Am een J Med Sci6, 163–6 (2013).
  5. Jayalakshmi, L., Ratnakumari, G. and Samson, S. H. Isolation , Speciation and Antifungal Susceptibility Testing of Candida from Clinical Specimens at a Tertiary Care Hospital. 2, 3193–3198 (2014).
  6. J, C. Textbook of Mycology. (Mehta publishers, 2009).
  7. JW, R. Candidiasis and the Pathogenic yeasts. In Medical Mycology. (WBSaunders Philadelphia, 1982).
  8. Madhumati, B. and Rajendran, R. Original Research Article Evaluation of Chrom Agar in Speciation of Candida Species from Various Clinical Samples in a Tertiary Care Hospital. 4, 463–472 (2015).
  9. Manchanda, V., Agarwal, N., V. Yeast identification in routine clinical Microbiology laboratory and its clinical relevance. Indian J. Med. Microbiol.,29, 172 (2011).
  10. Merz WG, H. R. T. and W. Medical Microbiology and Microbial infections, Medical Mycology. (Edward Arnold, 2005).
  11. Mohan, S. and Karthikeyan, D. Speciation and Antifungal Susceptibility Pattern of Candida Isolated from Clinical Specimens. 5, 820–824 (2016).
  12. Moran, G.P., Sullivan, D.J., Coleman, D. C. Emergence of non-Candida albicans Candida species as pathogens. In: Calderone RA. Candida and Candidiasis.4, (2002).
  13. Mukhia, R. K., Sah, R. P. and Arif, D. ISOLATION AND SPECIATION OF CANDIDA SPECIES FROM VARIOUS CLINICAL SPECIMENS IN A TERTIARY CARE HOSPITAL OF NAVI MUMBAI. 36–38 (2016).
  14. Nayak S, Kavitha B, Sriram G, Saraswathi TR, S. B. and AL., D. Comparative study of Candida by conventional and CHROMagar method in non-denture and denture wearers by oral rinse technique. Indian J Dent Res23, 490–7 (2012).
  15. Nirkhiwale, S., Bandi, A., Pahwa, N. and Kumar, R. Species distribution and drug susceptibility of candida in clinical isolates from a tertiary care centre at Indore. Indian J. Med. Microbiol.32, 44 (2014).
  16. Odds FC, B. R. CHROM agar Candida, a new differential isolation medium for presumptive identification of clinically important Candida spp. J. Clin. Microbiol.32, 1923–1929 (1994).
  17. Pinjon, E., Sullivan, D., Salkin, I., Shanley, D. and Coleman, D. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J. Clin. Microbiol.36, 2093–2095 (1998).
  18. Sagar, K., Mangalkar, S. and Gohel, T. Isolation of Different Candida Species from Clinical Samples and Comparison between Conventional and Hicrome Technique of Identification. 4, 3095–3101 (2015).
  19. Shaheen MA, T. M. Species identification of Candida isolates from oral lesions of hospitalized and non hospitalized patients with oral candidiasis. Egypt. Derm online Journal,2, 1–13 (2006).
  20. S., Reddy, K.M., Karjigi, K.S., Hittinahalli, V. Speciation of Candida using chromogenic and cornmeal agar with determination of fluconazole sensitivity.Al Ameen J. Med. Sci.6, 163–166. (2013).
  21. S Shivaprakasha, K Radhakrishnan, P. K. CANDIDA SPP. OTHER THAN CANDIDA ALBICANS: A MAJOR CAUSE OF FUNGAEMIA IN A TERTIARY CARE CENTRE. Indian J. Med. Microbiol.25(4), 405–7 (2012).
  22. Sumitra Devi, L. and Maheshwari, M. Speciation of Candida Species Isolated From Clinical Specimens by Using Chrom Agar and Conventional Methods. Int. J. Sci. Res. Publ.4, 2250–3153 (2014).
  23. Vijaya, D., Harsha, T.R., Nagaratnamma, T. Candida speciation using chrom agar. J. Clin. Diag. Res.5, 75–57. (2011).
  24. Wabale V, Kagal A, B. R. Characterization of Candida species from oral thrush in human immunodeficiency virus seropositive and seronegative patients. Bombay Hosp Journal,50, 119–121.




































 








 




 








 

 









Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.